Literature DB >> 31047626

Circulating Tumor DNA to Personalize Treatment in Nasopharynx Cancer - Time to Look "Ahead"?

Melvin L K Chua1.   

Abstract

Mesh：

Substances：

Year:  2019        PMID： 31047626     DOI： 10.1016/j.ijrobp.2019.02.043

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN： 0360-3016            Impact factor:   7.038


× No keyword cloud information.
  2 in total

Review 1.  Emerging radiotherapy technologies and trends in nasopharyngeal cancer.

Authors:  Michelle Tseng; Francis Ho; Yiat Horng Leong; Lea Choung Wong; Ivan Wk Tham; Timothy Cheo; Anne Wm Lee
Journal:  Cancer Commun (Lond)       Date:  2020-08-03

2.  Optimal sequencing of chemotherapy with chemoradiotherapy based on TNM stage classification and EBV DNA in locoregionally advanced nasopharyngeal carcinoma.

Authors:  Li-Ting Liu; Melvin L K Chua; Yungan Tao; Lin-Quan Tang; Hai-Qiang Mai
Journal:  Cancer Commun (Lond)       Date:  2019-10-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.